Omeros Corp (OMER)
Omeros stock today
Omeros closed at $18.44 on October 30, 2026, down 2.69% on the day. Over the past year it returned +145.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.33 billion.
| Period | OMER | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.2% | -0.9% |
| 3 months | +54.6% | +2.1% |
| Year to date | +7.4% | +11.7% |
| 1 year | +145.2% | +12.4% |
| 3 years | +1,518% | +88.5% |
| 5 years | +194.1% | +76.0% |
Key statistics
- Market value
- $1.33B
- P/E (trailing)
- 10.7
- Price / sales
- 34.8
- 52-week range
- $6.28 to $21.05
- Next report
- Nov 12, 2026 (estimated)
About Omeros
Pharmaceutical company developing therapies targeting unmet medical needs in specialized areas.
Sector: Health Care
More on Omeros
- Financials: revenue, earnings and segmentsRevenue -54% in the year to Dec 2018
- Valuation: P/E history and peersP/E 10.7
- Returns: what $1,000 became$1,000 ten years ago is $2,349 today
No forecast, no recommendation. This page describes Omeros Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.